Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$760M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$430M |
| 3 |
NVIDIA
NVDA
|
+$287M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$268M |
| 5 |
XYZ
Block Inc
XYZ
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$475M |
| 2 |
Pfizer
PFE
|
+$356M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$325M |
| 4 |
Apple
AAPL
|
+$325M |
| 5 |
Microsoft
MSFT
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17% |
| 2 | Financials | 12.96% |
| 3 | Healthcare | 12.18% |
| 4 | Consumer Discretionary | 8.39% |
| 5 | Industrials | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PDM
2026
Piedmont Realty Trust
PDM
$1.2B
| $5.42M | ﹤0.01% |
317,936
+119,610
| +60% | +$2.17M |
|
|
INVX
2027
Innovex International
INVX
$2.15B
| $5.41M | ﹤0.01% |
180,148
+2,250
| +1% | +$90.8K |
|
|
JPI
2028
DELISTED
Nuveen Preferred Securities & Income Opportunities Fund
JPI
| $5.41M | ﹤0.01% |
267,476
+11,959
| +5% | +$256K |
|
|
ERF
2029
DELISTED
Enerplus Corporation
ERF
| $5.4M | ﹤0.01% |
695,986
-3,228
| -0.5% | -$31.4K |
|
|
BXMX
2030
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
| $5.4M | ﹤0.01% |
447,018
+3,919
| +0.9% | +$51.6K |
|
2031
Franklin US Low Volatility High Dividend Index ETF
LVHD
$630M
| $5.38M | ﹤0.01% |
187,711
+4,709
| +3% | +$143K |
|
|
CRAY
2032
DELISTED
Cray, Inc.
CRAY
| $5.36M | ﹤0.01% |
248,342
-68,554
| -22% | -$1.55M |
|
|
UNVR
2033
DELISTED
Univar Solutions Inc.
UNVR
| $5.36M | ﹤0.01% |
302,252
-4,008
| -1% | -$92.8K |
|
2034
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$3.09B
| $5.34M | ﹤0.01% |
717,009
+26,757
| +4% | +$228K |
|
2035
Tompkins Financial
TMP
$1.45B
| $5.33M | ﹤0.01% |
71,128
-50
| -0.1% | -$3.83K |
|
|
CTRL
2036
DELISTED
Control4 Corporation
CTRL
| $5.33M | ﹤0.01% |
303,101
+51,959
| +21% | +$1.23M |
|
2037
M/I Homes
MHO
$3.9B
| $5.33M | ﹤0.01% |
253,730
-696
| -0.3% | -$16.1K |
|
|
DEA
2038
Easterly Government Properties
DEA
$1.18B
| $5.33M | ﹤0.01% |
136,009
+937
| +0.7% | +$41.7K |
|
2039
World Acceptance Corp
WRLD
$875M
| $5.33M | ﹤0.01% |
52,092
+2,575
| +5% | +$265K |
|
|
DVAX
2040
DELISTED
Dynavax Technologies
DVAX
| $5.32M | ﹤0.01% |
581,293
+91,330
| +19% | +$1.01M |
|
2041
CareDx
CDNA
$2.45B
| $5.3M | ﹤0.01% |
210,979
+12,495
| +6% | +$321K |
|
2042
iShares Global Energy ETF
IXC
$2.74B
| $5.3M | ﹤0.01% |
189,292
-136,541
| -42% | -$4.6M |
|
2043
Insmed
INSM
$27.6B
| $5.3M | ﹤0.01% |
403,629
+31,883
| +9% | +$509K |
|
|
MSGN
2044
DELISTED
MSG Networks Inc.
MSGN
| $5.29M | ﹤0.01% |
224,762
+184,344
| +456% | +$4.71M |
|
|
VTLE
2045
DELISTED
Vital Energy
VTLE
| $5.28M | ﹤0.01% |
72,947
-6,494
| -8% | -$682K |
|
2046
JPMorgan Diversified Return Emerging Markets Equity ETF
JPEM
$390M
| $5.28M | ﹤0.01% |
103,936
-41,322
| -28% | -$2.13M |
|
2047
Sanofi
SNY
$105B
| $5.28M | ﹤0.01% |
121,611
+8,957
| +8% | +$395K |
|
2048
Dycom Industries
DY
$12.3B
| $5.28M | ﹤0.01% |
97,654
-5,573
| -5% | -$374K |
|
2049
A.O. Smith
AOS
$8.49B
| $5.27M | ﹤0.01% |
123,518
-18,445
| -13% | -$849K |
|
2050
Heritage Insurance Holdings
HRTG
$989M
| $5.19M | ﹤0.01% |
352,494
-5,269
| -1% | -$78.4K |
|
Similar funds
Ameriprise's Q4 2018 Portfolio in Review
As of Q4 2018, Ameriprise held 3,899 positions worth $200B, down 30% from $286B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Ameriprise's Q4 2018 filing shows 170 new, 1,630 increased, 1,715 reduced and 248 closed positions. Its largest new stake was Linde: 460,065 shares worth $71.8M. The largest sale was Express Scripts Holding Company, an estimated $475M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q4 2018 buy was Linde: 460,065 shares worth $71.8M.
- Ameriprise added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q4 2018, an estimated $760M increase.
- Ameriprise's biggest Q4 2018 reduction was Pfizer, cutting an estimated $356M.
- Ameriprise fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $475M.
- Ameriprise's ten largest holdings make up 14% of its $200B portfolio in Q4 2018.
- Ameriprise opened 170 new positions and closed 248 in Q4 2018.
- Ameriprise's portfolio value fell 30% quarter-over-quarter to $200B.
Based on Ameriprise's 13F filing for Q4 2018, filed 14 Feb 2019.